A 1-month-old infant with chylomicronemia due to GPIHBP1 gene mutation treated by plasmapheresis
Mo Kyung Jung, Juhyun Jin, Hyun Ok Kim, Ahreum Kwon, Hyun Wook Chae, Seok Jin Kang, Duk Hee Kim, Ho-Seong Kim
Ann Pediatr Endocrinol Metab. 2017;22(1):68-71.   Published online 2017 Mar 31     DOI: https://doi.org/10.6065/apem.2017.22.1.68
Citations to this article as recorded by Crossref logo
Case Report: Successful Management of a 29-Day-Old Infant With Severe Hyperlipidemia From a Novel Homozygous Variant of GPIHBP1 Gene
Shu Liu, Zhiqing Wang, Xianhua Zheng, Ye Zhang, Sisi Wei, Haimei OuYang, Jinqun Liang, Nuan Chen, Weihong Zeng, Jianhui Jiang
Frontiers in Pediatrics.2022;[Epub]     CrossRef

Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy

Oluwayemisi Esan, Anthony S Wierzbicki
Drug Design, Development and Therapy.2020; Volume 14: 2623.     CrossRef
Gpihbp1 deficiency accelerates atherosclerosis and plaque instability in diabetic Ldlr-/- mice
Xuejing Liu, Jingyi Li, Jiawei Liao, Huan Wang, Xiaomin Huang, Zhao Dong, Qiang Shen, Ling Zhang, Yuhui Wang, Wei Kong, George Liu, Wei Huang
Atherosclerosis.2019; 282: 100.     CrossRef
Therapeutic Plasma-albumin Exchange for Hyperlipidemia Induced Acute Pancreatitis
Stavroula Ilia, Elisavet Geromarkaki, Marianna Miliaraki, George Briassoulis
Journal of Pediatric Gastroenterology & Nutrition.2018; 66(6): e162.     CrossRef
Familial chylomicronemia – a rare cause of dyslipidemia in newborn
Ioana Țieranu, Maria Gica, Adrian Stanciu, Mihaela Bălgrădean
Pediatru.ro.2018; 4(52): 44.     CrossRef